Distribution of 4'epi-doxorubicin in human tissues.
作者信息
Italia C, Paglia L, Trabattoni A, Luchini S, Villas F, Beretta L, Marelli G, Natale N
出版信息
Br J Cancer. 1983 Apr;47(4):545-7. doi: 10.1038/bjc.1983.86.
Abstract
摘要
相似文献
1
Distribution of 4'epi-doxorubicin in human tissues.4'-表阿霉素在人体组织中的分布。
Br J Cancer. 1983 Apr;47(4):545-7. doi: 10.1038/bjc.1983.86.
2
Phase II evaluation of 4'epi-doxorubicin in patients with metastatic colorectal carcinoma.
Tumori. 1984 Jun 30;70(3):297-300. doi: 10.1177/030089168407000317.
3
Comparative pharmacokinetic study of adriamycin and 4'epi-adriamycin after their simultaneous intravenous administration.
Eur J Clin Pharmacol. 1986;30(5):629-31. doi: 10.1007/BF00542426.
4
Phase II trial of 4'epi-adriamycin for advanced hypernephroma.
Am J Clin Oncol. 1983 Oct;6(5):553-4.
5
A pharmacokinetic study of adriamycin and 4'epi-adriamycin after simultaneous intra-arterial liver administration.
Med Oncol Tumor Pharmacother. 1986;3(2):105-10. doi: 10.1007/BF02934562.
6
Pharmacokinetics and central haemodynamic effects of doxorubicin and 4'epi-doxorubicin in the pig.
Acta Oncol. 1989;28(5):709-14. doi: 10.3109/02841868909092298.
7
Phase II study of 4'epi-doxorubicin.
Tumori. 1982 Oct 31;68(5):431-5. doi: 10.1177/030089168206800513.
8
Pharmacokinetics of anthracyclines.
Acta Oncol. 1989;28(6):873-6. doi: 10.3109/02841868909092323.
9
Evaluation of anthracycline cardiotoxicity with the model of isolated, perfused rat heart: comparison of new analogues versus doxorubicin.采用离体灌注大鼠心脏模型评估蒽环类药物的心脏毒性：新型类似物与多柔比星的比较
Cancer Chemother Pharmacol. 1995;35(3):257-61. doi: 10.1007/BF00686558.
10
Doxorubicinolone formation and efflux: a salvage pathway against epirubicin accumulation in human heart.多柔比星醇的形成与外排：一种对抗表柔比星在人心脏中蓄积的挽救途径。
J Pharmacol Exp Ther. 2009 Apr;329(1):175-84. doi: 10.1124/jpet.108.149260. Epub 2009 Jan 14.
引用本文的文献
1
Study on the infusion-site adverse events and vascular distribution of epirubicin in chemotherapy with epirubicin and fosaprepitant.表柔比星与磷丙泊酚替罗非联合化疗中表柔比星输注部位不良事件及血管分布的研究
Mol Clin Oncol. 2019 Jul;11(1):43-49. doi: 10.3892/mco.2019.1849. Epub 2019 Apr 24.
2
Clinical pharmacokinetics of epirubicin.表柔比星的临床药代动力学
Clin Pharmacokinet. 1994 Jun;26(6):428-38. doi: 10.2165/00003088-199426060-00002.
3
Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy.表柔比星。对其药效学和药代动力学特性以及在癌症化疗中的治疗应用的综述。
Drugs. 1993 May;45(5):788-856. doi: 10.2165/00003495-199345050-00011.
4
Cellular and plasma pharmacokinetics of weekly 20-mg 4'-epi-adriamycin bolus injection in patients with advanced breast carcinoma.
Cancer Chemother Pharmacol. 1986;18(1):78-82. doi: 10.1007/BF00253070.
本文引用的文献
1
Studies on the comparative distribution and biliary excretion of doxorubicin and 4'-epi-doxorubicin in mice and rats.阿霉素和4'-表阿霉素在小鼠和大鼠体内的比较分布及胆汁排泄研究。
Cancer Treat Rep. 1980 Aug-Sep;64(8-9):897-904.
2
Plasma and urinary levels of adriamycin in man.人体内阿霉素的血浆和尿液水平。
Eur J Cancer (1965). 1972 Aug;8(4):455-9. doi: 10.1016/0014-2964(72)90132-6.
3
Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function.阿霉素及其代谢产物在肝肾功能正常的人体中的血浆药代动力学。
Cancer Res. 1977 May;37(5):1416-20.
4
Prediction of adriamycin disposition in cancer patients using a physiologic, pharmacokinetic model.
Cancer Treat Rep. 1978 Aug;62(8):1161-71.
5
In vitro uptake and cytotoxicity of adriamycin in primary and metastatic Lewis lung carcinoma.阿霉素在原发性和转移性Lewis肺癌中的体外摄取及细胞毒性
Eur J Cancer (1965). 1979 Sep;15(9):1121-9. doi: 10.1016/0014-2964(79)90128-2.
6
Preliminary phase I study of 4'-epi-adriamycin.
Cancer Treat Rep. 1979 May;63(5):915-8.
Zotero 插件